Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Leiomyosarcoma Uterus × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 845 Glioblastoma 280 Gliosarcoma 272 Osteosarcoma 242 Brain Neoplasms 184 Dendritic Cell Sarcoma, Interdigitating 166 Gastrointestinal Stromal Tumors 163 Central Nervous System Neoplasms 152 Bone Neoplasms 150 Astrocytoma 146 Lymphoma 144 Glioma 139 Sarcoma, Ewing 137 Precursor Cell Lymphoblastic Leukemia-Lymphoma 132 Lymphoma, Non-Hodgkin 129 Neoplasms 124 Burkitt Lymphoma 124 Oligodendroglioma 119 Recurrence 115 Neuroblastoma 115 Lymphoma, Large B-Cell, Diffuse 115 Lymphoma, Follicular 113 Rhabdomyosarcoma 111 Hodgkin Disease 110 Breast Neoplasms 109 Leukemia, Myeloid, Acute 105 Lymphoma, Mantle-Cell 104 Leukemia, Lymphocytic, Chronic, B-Cell 104 Leukemia 102 Lymphoma, B-Cell, Marginal Zone 99

Interventions

Trabectedin 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06524583 2025-03-30

L-UteCIN

UNICANCER

Phase 2 Recruiting

Leiomyosarcoma Uterus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡